Name File Type Size Last Modified
Copy of MDA DATASET-Filled WR 20.12.2024.xls application/vnd.ms-excel 674 KB 08/07/2025 12:44:AM

Project Citation: 

Okungu, Vincent. Strengthening the sustainability of neglected tropical disease programs in Rwanda. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2025-08-07. https://doi.org/10.3886/E237121V1

Project Description

Summary:  View help for Summary Strengthening the sustainability of neglected tropical disease programs in Rwanda: An assessment of access and utilization of domestically-financed services for Soil-Transmitted Helminthiases and Schistosomiasis   Introduction: Soil-transmitted helminth (STH) and schistosomiasis (SCH) infections remain some of the most prevalent neglected tropical diseases (NTDs), causing significant morbidity in most of sub-Saharan Africa (SSA), including Rwanda. With dwindling international funding for NTD services and recent commitments focused on other diseases considered easier to eliminate as a public health problem, it is essential to assess domestic financing sources' scale, efficiency, and effectiveness. The study aims to strengthen domestic efforts towards sustainable financing for neglected tropical disease programs in Africa, particularly in Rwanda. Method: Up to 235 patients from 24 health centers in four districts of Rwanda were sampled for this survey. The districts selected had the highest number of STH and SCH based on routine data from June 2021 to December 2022, which is the window period of the study. We estimated affordability using the lowest-paid government worker (LPGW) and then compared this with household income and expenditure obtained from patients participating in the survey. Data was collected from August to September 2023. Limited secondary data were collected to complement primary data. Descriptive statistical analysis was used to present the findings. Results and Conclusions: The most available drugs were mebendazole, with 100% of facilities reporting no stockout. Praziquantel (PZQ) was the most unavailable drug, reporting 92% stockout at the time of the survey, mainly due to delays in getting supplies from MDA-implementing health facilities. Diagnostics for SCH are the most inaccessible lab services. On average, the total cost (both direct and opportunity cost) to access and utilize STH and SCH services was USD 0.72 (RWF 861.92) and USD 0.96 (RWF 1136.41) for male and female patients, respectively. Although the assessment revealed that treatment for STH and SCH was affordable for the LPGW, women pay a 33% higher cost than men to access NTD services. While services are generally satisfactory, the reimbursement processes are slow, hindering timely access and utilization of SCH and STH services at the health facilities in Rwanda. While the access and utilization of STH and SCH services in health centers are generally promising, the findings underscore the potential for improvement. By addressing the efficiency in the supply of praziquantel drugs and enhancing reimbursement timelines, we can ensure the continuity and effectiveness of these services, offering hope for a brighter future in the fight against neglected tropical diseases.

Scope of Project

Subject Terms:  View help for Subject Terms Neglected Tropical Diseases; Rwanda; Financing; Schistosomiasis; STH
Geographic Coverage:  View help for Geographic Coverage Rwanda
Time Period(s):  View help for Time Period(s) 1/1/2023 – 5/1/2025
Collection Date(s):  View help for Collection Date(s) 8/1/2023 – 9/30/2023
Universe:  View help for Universe N/A
Data Type(s):  View help for Data Type(s) survey data
Collection Notes:  View help for Collection Notes N/A

Methodology

Response Rate:  View help for Response Rate 85%
Sampling:  View help for Sampling Up to 235 patients from 24 sampled health centers in four districts of Rwanda were sampled for this survey. 
Data Source:  View help for Data Source Individual interviews and health facility records
Collection Mode(s):  View help for Collection Mode(s) coded on-site observation; face-to-face interview; on-site questionnaire
Scales:  View help for Scales N/A
Weights:  View help for Weights N/A
Unit(s) of Observation:  View help for Unit(s) of Observation Individuals
Geographic Unit:  View help for Geographic Unit Districts

Related Publications

Release of this data has been delayed until 01/01/2027 at the request of the depositor.

Published Versions

Export Metadata

Report a Problem

Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.

This material is distributed exactly as received from the data depositor. As of April 2026, depositors are required to submit study materials in accessible formats. ICPSR has not reviewed, checked, or processed this material. For additional information about the study, please contact the investigator(s) directly. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR's Accessibility Center.